Sen-Jam Pharmaceutical
Early Stage
Own a stake for health equality; affordable and accessible for all
Overview
Platform
Self Managed
Start Date
04/24/2023
Close Date
Not Provided
Min. Goal
$10,000,000
Max. Goal
$10,000,000
Min. Investment
$0
Security Type
Convertible Note
Series
Series A
SEC Filing Type
RegD 506(c)
Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Location
Huntington, New York
Sen-Jam Pharmaceutical, with a valuation of $70 million, is raising funds on Dealmaker Securities with a Reg D 506(c) raise. The pharmaceutical company makes highly accessible, safe, and affordable drugs that work. The drugs of Sen-Jam Pharmaceutical combine NSAIDs and antihistamines to prevent inflammation and associated pain. Sen-Jam Pharmaceutical is majorly targeting opioid withdrawal, alcohol hangover prevention, and COVID-19 therapeutic. The company has a strong global IP portfolio with 40 patents and world-class partners. Jim Iversen and Jackie Iversen founded Sen-Jam Pharmaceutical in August 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $10 million. The campaign proceeds will be used to advance the different phases of its clinical trials.
Create a free account today to gain access to KingsCrowd analytics.
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Sen-Jam Pharmaceutical | 04/28/2024 | Wefunder | $80,000,000 | $1,036,128 | Convertible Note | Active | RegCF |
| Sen-Jam Pharmaceutical | 01/05/2024 | Self Managed | - | - | Convertible Note | Funded | RegD 506(c) |
| Sen-Jam Pharmaceutical | 01/10/2023 | StartEngine | $69,979,019 | $312,093 | Equity - Common | Funded | RegCF |
| Sen-Jam Pharmaceutical | 07/30/2022 | Wefunder | $25,000,000 | $1,008,951 | Convertible Note | Funded | RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.